Provided by Tiger Fintech (Singapore) Pte. Ltd.

Check-Cap

0.6687
+0.01872.88%
Volume:13.34K
Turnover:8.70K
Market Cap:3.91M
PE:-0.31
High:0.6688
Open:0.6373
Low:0.6372
Close:0.6500
Loading ...

Company Profile

Company Name:
Check-Cap
Exchange:
NASDAQ
Establishment Date:
2004
Employees:
85
Office Location:
Check-Cap Building,29 Abba Hushi Avenue,PO Box 1271,Isfiya,Israel
Zip Code:
3009000
Fax:
972 4 821 1267
Introduction:
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.

Directors

Name
Position
Steven Hanley
Chairman of the Board of Director
Clara Ezed
Director
Mary Jo Gorman
Director
XiangQian Lin
Director
Yuval Yanai
Director

Shareholders

Name
Position
Alex Ovadia
Chief Executive Officer
Mira Rosenzweig
Chief Financial Officer
Boaz Shpigelman
Vice President, Research and Development
Israel Hershko
Vice President, Quality Assurance and Regulatory Affairs
Joshua Belkar
Vice President, Operations
Vardit Segal
Vice President, Clinical Affairs
Yoav Kimchy
Chief Technology Officer